Show document

A+ | A- | | SLO | ENG

Title: Neželeni učinki biološkega zdravila evolokumab za zdravljenje dislipidemije Authors: ID Nikolić, Nataša (Author) Files: URL - Source URL, visit https://www.sfd.si/wp-content/uploads/2025/10/nikolic.pdf   PDF - Presentation file, download (144,99 KB) MD5: BB6BB6FD0A450440E2B1EF5F0E1AD655   Language: Slovenian Typology: 1.03 - Other scientific articles Organization: SFD - Slovenian Pharmaceutical Society Keywords: dislipidemije, hiperholesterolemija, vloga farmacevta, klinični primer, evolokumab Publication status: Published Publication version: Version of Record Publication date: 01.10.2025 Year of publishing: 2025 Number of pages: str. 282-287 Numbering: Letn. 76, št. 4 PID: 20.500.12556/DiRROS-30619  UDC: 615 ISSN on article: 0014-8229 COBISS.SI-ID: 272032515  Note: Besedilo v slov.; Publication date in DiRROS: 30.06.2026 Views: 30 Downloads: 18 Metadata:    Cite this work Plain text BibTeX EndNote XML EndNote/Refer RIS ABNT ACM Ref AMA APA Chicago 17th Author-Date Harvard IEEE ISO 690 MLA Vancouver : Copy citation

Share: Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:	Farmacevtski vestnik : strokovno glasilo slovenske farmacije
Shortened title:	Farm. vestn.
Publisher:	Slovensko farmacevtsko društvo
ISSN:	0014-8229
COBISS.SI-ID:	3105794

Licences

License:	CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:	http://creativecommons.org/licenses/by-nc/4.0/
Description:	A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:	English
Title:	Evolocumab adverse reactions in treatment of dyslipidemia
Keywords:	dyslipidemia, evolocumab, clinical case, hypercholesterolemia, pharmaceutical role

Collection

This document is a part of these collections:

1. Farmacevtski vestnik

Back